UpdatesPress Release
Emcure's Poviztra® (semaglutide) received CDSCO approval for MASH treatment, expanding its market into a significant unmet medical need.
Emcure Pharmaceuticals LimitedEMCURE · Filed with the exchange
This makes it the first GLP-1 receptor agonist approved for this progressive liver disease in India, bolstering Emcure's metabolic portfolio.
No comments yet. Be the first.